Terms: = Skin cancer AND TG, Thyroglobulin AND Prognosis
12 results:
1. The transmembrane protein LRIG1 triggers melanocytic tumor development following chemically induced skin carcinogenesis.
Hoesl C; Fröhlich T; Posch C; Kneitz H; Goebeler M; Schneider MR; Dahlhoff M
Mol Oncol; 2021 Aug; 15(8):2140-2155. PubMed ID: 33786987
[TBL] [Abstract] [Full Text] [Related]
2. Unusual metastases from differentiated thyroid cancers: A multicenter study in Korea.
Yoon JH; Jeon MJ; Kim M; Hong AR; Kim HK; Shin DY; Kim BH; Kim WB; Shong YK; Kang HC
PLoS One; 2020; 15(8):e0238207. PubMed ID: 32841270
[TBL] [Abstract] [Full Text] [Related]
3. Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody.
Matsuoka H; Hayashi T; Takigami K; Imaizumi K; Shiroki R; Ohmiya N; Sugiura K; Kawada K; Sawaki A; Maeda K; Ando Y; Uyama I
BMC Cancer; 2020 Jul; 20(1):656. PubMed ID: 32664888
[TBL] [Abstract] [Full Text] [Related]
4. Outcomes and Predictors of Response in Steroid-Refractory Acute Graft-versus-Host Disease.
Rashidi A; DeFor TE; Holtan SG; Blazar BR; Weisdorf DJ; MacMillan ML
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2297-2302. PubMed ID: 31325587
[TBL] [Abstract] [Full Text] [Related]
5. Polymorphisms in apoptosis-related genes in cutaneous melanoma prognosis: sex disparity.
Oliveira C; Lourenço GJ; Rinck-Junior JA; de Moraes AM; Lima CS
Med Oncol; 2017 Feb; 34(2):19. PubMed ID: 28050764
[TBL] [Abstract] [Full Text] [Related]
6. [Scalp metastasis as the first manifestation of mixed follicular-papillary thyroid cancer].
Junquera Bañares S; Oria Mundín E; Tuñón Alvarez T; Vázquez Martínez C; Botella Carretero JI
An Sist Sanit Navar; 2014; 37(2):281-6. PubMed ID: 25189986
[TBL] [Abstract] [Full Text] [Related]
7. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
Brose MS; Nutting CM; Jarzab B; Elisei R; Siena S; Bastholt L; de la Fouchardiere C; Pacini F; Paschke R; Shong YK; Sherman SI; Smit JW; Chung J; Kappeler C; Peña C; Molnár I; Schlumberger MJ;
Lancet; 2014 Jul; 384(9940):319-28. PubMed ID: 24768112
[TBL] [Abstract] [Full Text] [Related]
8. Unusual metastases from tall cell variant of papillary thyroid cancer.
Pagano L; Caputo M; Samà MT; Zavattaro M; Prodam F; Mauri MG; Pia F; Alonzo A; Valente G; Aimaretti G
Head Neck; 2013 Dec; 35(12):E381-5. PubMed ID: 23595984
[TBL] [Abstract] [Full Text] [Related]
9. Potential of MR mammography to predict tumor grading of invasive breast cancer.
Dietzel M; Baltzer PA; Vag T; Zoubi R; Gröschel T; Burmeister H; Gajda M; Runnebaum IB; Kaiser WA
Rofo; 2011 Sep; 183(9):826-33. PubMed ID: 21442559
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathologic features and BRAF(V600E) mutation analysis in cutaneous metastases from well-differentiated thyroid carcinomas.
Erickson LA; Jin L; Nakamura N; Bridges AG; Markovic SN; Lloyd RV
Cancer; 2007 May; 109(10):1965-71. PubMed ID: 17387744
[TBL] [Abstract] [Full Text] [Related]
11. [Unusual metastasis of differentiated thyroid carcinoma].
Ferrer García JC; Merino Torres JF; Ponce Marco JL; Piñón Sellés F
An Med Interna; 2002 Nov; 19(11):579-82. PubMed ID: 12522895
[TBL] [Abstract] [Full Text] [Related]
12. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer.
Niwa Y; Akamatsu H; Niwa H; Sumi H; Ozaki Y; Abe A
Clin Cancer Res; 2001 Feb; 7(2):285-9. PubMed ID: 11234881
[TBL] [Abstract] [Full Text] [Related]
